HPGC Renmintongtai Pharmaceutical Corporation
SHH: 600829.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Cong Feng Gu
- Employees
- 2,870
- Headquarters
- Harbin, China
- IPO year
- 1994
- Market cap
- CN¥5.7B
- Website
- https://www.hyrmtt.com.cn
Loading 600829…
Loading profile data…Frequently asked questions about 600829
What does HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) do?
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provide...
Where does 600829.SS trade?
HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) trades on the Shanghai Stock Exchange.
What sector is 600829.SS in?
HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of HPGC Renmintongtai Pharmaceutical Corporation?
Cong Feng Gu is the chief executive officer of HPGC Renmintongtai Pharmaceutical Corporation (600829.SS).
Where is HPGC Renmintongtai Pharmaceutical Corporation headquartered?
HPGC Renmintongtai Pharmaceutical Corporation is headquartered in China.
Does 600829.SS pay a dividend?
Yes — HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) paid a trailing twelve-month dividend of CNY 0.14 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600829.SS go public?
HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) completed its initial public offering in 1994.